Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |